Exploring pain adaptation in youth with juvenile idiopathic arthritis: Identifying youth and parent resilience resources and mechanisms

Juvenile Idiopathic Arthritis

The Relationship of Fatigue, Pain Interference and Physical Disability in Children Newly Diagnosed with Juvenile Idiopathic Arthritis

Arthritis Care Res (Hoboken)

Choong N, Batthish M, Berard RA, Chédeville G, Feldman BM, Houghton KM, Huber AM, James S, Proulx-Gauthier JP, Rumsey DG, Schmeling H, Toupin-April K, Guzman J, CAPRI Registry Investigators

doi: 10.1002/acr.25377

Juvenile Idiopathic Arthritis

Transcriptomic profiling and immuno-histological characterization of synovial biopsies in juvenile idiopathic arthritis (JIA) suggest two broad categories, with significant overlap with rheumatoid arthritis (RA)

Arthritis Rheumatol

Triaille C, Tilman G, Baert CA, Sokolova T, Loriot A, Nzeusseu-Toukap A, Meric de Bellefon L, Galant C, Boulanger C, Fonseca JE, Bouzin C, Durez P, Lauwerys BR, Limaye N

doi: 10.1002/art.42922

Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Arthritis Care Res (Hoboken)

Miller H, Neovius M, Sundberg E, Askling J, Bruze G

doi: 10.1002/acr.25522

EULAR 2024

Juvenile Idiopathic Arthritis

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Juvenile Idiopathic Arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Arthritis Rheumatol

Tordoff M, Smith SL, Lawson-Tovey S, UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC, Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J, CLUSTER consortium

doi: 10.1002/art.42955

Juvenile Idiopathic Arthritis

Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment (PhGA) of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus

Arthritis Care Res (Hoboken)

Tarkiainen M, Balay-Dustrude E, Consolaro A, Morgan EM, Ruperto N, Rypdal V, Backström M, Vähäsalo P, Gottlieb BS, Paediatric Rheumatology International Trials Organisation, and the Pediatric Rheumatology Care & Outcomes Improvement Network and the PhGA consensus task force, For the Pediatric Rheumatology European Society (PRES) JIA working party

doi: 10.1002/acr.25447

Juvenile Idiopathic Arthritis

Incidence of juvenile idiopathic arthritis in Finland, 2000-2020

Rheumatology (Oxford)

Uusitupa E, Rahikkala H, Sard S, Pokka T, Salo H, Kärki J, Sokka-Isler T, Backström M, Vähäsalo P

doi: 10.1093/rheumatology/keae322

Juvenile Idiopathic Arthritis

Assessing Methotrexate Adherence in Juvenile Idiopathic Arthritis Using Electronic Health Record-Linked Pharmacy Dispensing Data

Arthritis Care Res (Hoboken)

Abel D, Anderson D, Kallan MJ, Utidjian L, Burnham JM, Chang JC, Kenyon CC, Gmuca S

doi: 10.1002/acr.25441

Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease

Ann Rheum Dis

De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S

doi: 10.1136/ard-2024-225853

Related content

The Relationship of Fatigue, Pain Interference and Physical Disability in Children Newly Diagnosed with Juvenile Idiopathic Arthritis

Transcriptomic profiling and immuno-histological characterization of synovial biopsies in juvenile idiopathic arthritis (JIA) suggest two broad categories, with significant overlap with rheumatoid arthritis (RA)

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment (PhGA) of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus

Incidence of juvenile idiopathic arthritis in Finland, 2000-2020

Assessing Methotrexate Adherence in Juvenile Idiopathic Arthritis Using Electronic Health Record-Linked Pharmacy Dispensing Data

Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease